Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹22.31 Cr |
| Reserved for Market Maker | ₹1.12 Cr |
| Net Issue Size | ₹22.31 Cr |
| Fresh Issue | ₹16.74 Cr |
| Offer for Sale | ₹4.45 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹51.00-54.00 per share |
| NSE Code | GML |
| Registrar | Cameo Corporate Services Ltd. |
| Lead Managers | Affinity Global Capital Market... |
| Allotment Status |
| DRHP |
| RHP |
| Final Prospectus |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 4,000 shares · Multiples of 2,000 shares
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.
The company manufactures these products using premium grade raw material that is procured from the authentic vendors of the market.
The company specializes in various products, including surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, and wound care solutions.
Their offerings meet diverse medical needs, including gauze products and orthopedic items.
The company's business includes the following:-
The company has 27 registered trademarks in India, serving domestic and international markets.
The company's products are accepted by the medical community and supplied throughout India to government health departments, corporate hospitals, and private entities.
The company complies with ISO 9001:2015 and ISO 13485:2016 certifications, ensuring that its products meet the rigorous demands of healthcare institutions.
As of March 2025, the company has 190 employees in various departments.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | . Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha | 4.89 |
| 2 | Funding the working capital requirements | 8.94 |
| 3 | General Corporate Purposes | 2.25 |
| 4 | To meet the offer related expenses | 1.79 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 31.49 | 32.53 | 32.31 |
| Total Income | 40.27 | 36.94 | 32.03 |
| Profit After Tax | 3.37 | 3.71 | 1.57 |
| EBITDA | 4.58 | 5.26 | 3.14 |
| NET Worth | 18.36 | 15.54 | 11.94 |
| Reserves and Surplus | 12.29 | 9.51 | 14.78 |
| Total Borrowing | 4.61 | 8.12 | 9.15 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 19.88% |
| ROCE | 22.38% |
| Debt / Equity | 0.25% |
| RoNW | 18.35% |
| PAT Margin | 8.60% |
| EBITDA Margin | 11.69% |
| Price to Book Value | 3.49 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 2.84 | 2.22 |
| P/E (x) | 19.01 | 24.31 |
| Promoter Holding | 99.57% | 72.43% |
| Market Cap | ₹81.93 Cr. | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Manager Fees | 1.35 |
| 2 | Underwriting Fees | 0.55 |
| 3 | Fees Payable to the Market Maker to the Issue | 0.03 |
| 4 | Fees Payable to the Registrar to the Issue | 0.01 |
| 5 | Fees Payable for Advertising and Publishing expenses | 0.10 |
| 6 | Fees payable to Regulators including Stock Exchange and Depositories | 0.12 |
| 7 | Payment fees for Printing & Stationery, Postages, etc | 0.00 |
| 8 | Fees payable to Statutory Auditor, Legal Advisors and other Professionals | 0.03 |
| 9 | Concurrent Auditor | 0.00 |
| 10 | Others | 0.04 |
Last Updated on 16-Jun-2026 18:10:14
